Neurotransmitters show correlation with personality

Article

With the help of PET, German researchers have established a correlation between healthy people's personalities and their brain chemistry.

Lead investigator Dr. Peter Bartenstein, a professor of nuclear medicine at Ludwig Maximilians-University in Munich, supervised the examination of 23 healthy men with no history of substance abuse with PET following administration of fluorine-18 fluoroethyl-diprenorphine, a radiolabeled tracer. It binds to endorphins occurring naturally in the brain's reward system. Researchers compared PET scans with results of a personality test and found that study subjects with a higher need for approval also showed the highest endorphin uptake. The results could lead to a better understanding and treatment of addictive behavior. They were published in the August issue of the Journal of Nuclear Medicine (2008;49 [8]:1257-1261).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.